Bartonella henselae Endocarditis: An Usual Presentation of an Unusual Disease

  • Aasem Abu Shtaya Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
  • Shoshan Perek Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
  • Adi Kibari Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel
  • Shai Cohen Department of Internal Medicine ‘B’, Lady Davis Carmel Medical Center, Haifa, Israel

Keywords

Infective endocarditis, Bartonella, cat-scratch disease

Abstract

Bartonella species are an emerging cause of culture-negative endocarditis with more cases being diagnosed now than 25 years ago when Bartonella quintana endocarditis was first described in a patient infected with human immunodeficiency virus (HIV). Despite the disease being increasingly reported, the exact epidemiological features are not clear, with prevalence rates ranging between 2% and 10% of all cases of culture-negative endocarditis. Moreover, the mortality rate is still high, presumably because of the subacute nature and relative rareness of the disease. Bartonella endocarditis occurs more often in men, and previous valvular surgery is a major risk factor. There is insufficient data to guide definitive treatment due to the paucity of literature. A previous study demonstrated that effective antibiotic therapy for Bartonella endocarditis should include an aminoglycoside prescribed for a minimum of 2 weeks. However, the treatment strategy is a matter of expert opinion

References

  • Fournier PE, Lelievre H, Eykyn SJ, Mainardi JL, Marrie TJ, Raoult D, et al. 2001. Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 2001;80:245–51. doi:10.1097/00005792-200107000-00003

  • Benslimani A, Fenollar F, Lepidi H, Raoult D. Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis 2005;11: 216–24.

  • Znazen A, Rolain JM, Hammami N, Kammoun S, Hammami A, Raoult D. High prevalence of Bartonella quintana endocarditis in Sfax, Tunisia. Am J Trop Med Hyg 2005;72:503–07.

  • Maurin M, Gasquet S, Ducco C, Raoult D. MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates. Antimicrob Agents Chemother 1995;39:2387–91.

  • Maurin M, Raoult D. Antimicrobial susceptibility of Rochalimaea quintana, Rochalimaea vinsonii and the newly recognized Rochalimaea henselae. J Antimcrob Chemother 1993;32:587–94.

  • Rolain JM, Maurin M, Raoult D. Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications. J Antimicrob Chemother 2000;46:811–14.
  • Published: 2019-03-04

    Issue: Vol 6 No 3 (view)

    Section: Articles

    How to cite:
    Abu Shtaya, A., Perek, S., Kibari, A., & Cohen, S. (2019). Bartonella henselae Endocarditis: An Usual Presentation of an Unusual Disease. European Journal of Case Reports in Internal Medicine, 6(3). https://doi.org/https://doi.org/10.12890/2019_001038